PROCEPT BioRobotics (PRCT) Cash from Financing Activities (2020 - 2026)
PROCEPT BioRobotics (PRCT) posted quarterly Cash from Financing Activities of $222000.0 for Q1 2026, down 82.9% year-over-year from $1.3 million in Q1 2025, and down 95.0% quarter-over-quarter from $4.4 million in Q4 2025.
PROCEPT BioRobotics (PRCT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Cash from Financing Activities for 7 consecutive years, with $222000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 82.9% year-over-year to $222000.0; the TTM figure through Mar 2026 stood at $10.1 million (down 94.34% YoY), while the FY2025 annual figure was $11.2 million, down 93.79% from the prior year.
- Cash from Financing Activities retreated to $222000.0 in Q1 2026 per PRCT's latest filing, from $4.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $170.5 million in Q4 2024 and bottomed at -$1.3 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged $21.3 million across 5 years, with a median of $2.4 million in 2023.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 304.66% — and 2023, when it jumped 20764.74%.
- PROCEPT BioRobotics' Cash from Financing Activities stood at -$1.3 million in 2022, then jumped by 317.45% to $2.9 million in 2023, then soared by 5850.03% to $170.5 million in 2024, then sank by 97.4% to $4.4 million in 2025, then tumbled by 95.0% to $222000.0 in 2026.
- Business Quant data shows PRCT's Cash from Financing Activities at $222000.0 in Q1 2026, $4.4 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -213.50 Mn |
| 10 | PROCEPT BioRobotics | 1.22 Bn | 940.44 Mn | 62.38 Mn | 4.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.50 Mn |
| Jun 30, 2026 | 4.50 Mn |
| Mar 31, 2026 | 222,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Dec 31, 2025 | 4.44 Mn |
| Dec 31, 2025 | 4.44 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 170.53 Mn |
| Dec 31, 2024 | 170.53 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |